Delayed Adverse Events after Procedural Sedation in Pediatric Patients with Hematologic Malignancies

被引:2
作者
Joo, Jin [1 ]
Yu, Sanghyuck [1 ]
Koh, Hyun Jung [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Seoul 06591, South Korea
来源
MEDICINA-LITHUANIA | 2022年 / 58卷 / 09期
关键词
adverse event; hematological malignancies; pediatric; procedural sedation; propofol; ketamine; OPERATING-ROOM; PROPOFOL; KETAMINE; COMBINATION; KETOFOL; ANESTHESIA; ANALGESIA; DEXMEDETOMIDINE; SAFETY;
D O I
10.3390/medicina58091208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Procedural sedation for bone marrow examination (BME) and intrathecal chemotherapy (ITC) is necessary for pediatric patients with hematological malignancies. There has been no report on adverse events after discharge from the recovery room. This retrospective study evaluated the types and incidences of delayed adverse events among pediatric patients scheduled for BME or ITC under deep sedation in a single center for 3 years. Materials and Methods: The patients were divided into two groups: inpatients (group I) and outpatients (group O). All patients were managed during the procedures and the recovery period. In total, 10 adverse events were assessed; these occurred 2 h (T1, acute), 12 h (T2, early), and 24 h (T3, delayed) after the procedure. The duration of each adverse event was also recorded and was classified as 2 h (D1), 12 h (D2), or 24 h (D3). The data of 263 patients (147 inpatients and 116 outpatients) who met the inclusion criteria were analyzed. Results: The overall incidence of adverse events was statistically significant difference: 48.3% in group I and 33.6% in group O (p = 0.011). The rates of adverse events at T1 and T2 were significantly different between groups I and O (42.8% vs. 11.2% and 7.5% vs. 20.7%, respectively) (p < 0.001). The adverse events were mostly of D1 or D2 duration in both groups. Patients with a higher proportion of ketamine in a propofol-ketamine mixture had a significantly higher proportion of adverse events at T1 (34.6%), as compared with those with a mixture with a lower proportion of ketamine (21.1%) or propofol alone (17.9%) (p = 0.012). Conclusions: The most common adverse events were dizziness or headache; typically, they did not last longer than 12 h. The propofol-ketamine combination with a higher proportion of ketamine seems to produce more adverse events within 2 h after the procedure. Nevertheless, all sedative types appear safe to use without additional management.
引用
收藏
页数:10
相关论文
共 36 条
  • [1] Afonso J, 2012, REV BRAS ANESTESIOL, V62, P118, DOI 10.1016/S0034-7094(12)70110-1
  • [2] Ketamine, Propofol, and Ketofol Use for Pediatric Sedation
    Alletag, Michelle J.
    Auerbach, Marc A.
    Baum, Carl R.
    [J]. PEDIATRIC EMERGENCY CARE, 2012, 28 (12) : 1391 - 1395
  • [3] [Anonymous], 2022, Pediatr Emerg Care, V38, P34, DOI 10.1097/01.pec.0000817604.24078.85
  • [4] Dexmedetomidine versus Midazolam in Procedural Sedation. A Systematic Review of Efficacy and Safety
    Barends, Clemens R. M.
    Absalom, Anthony
    van Minnen, Baucke
    Vissink, Arjan
    Visser, Anita
    [J]. PLOS ONE, 2017, 12 (01):
  • [5] Pediatric Sedation Management
    Barnes, Sean
    Yaster, Myron
    Kudchadkar, Sapna R.
    [J]. PEDIATRICS IN REVIEW, 2016, 37 (05) : 203 - 211
  • [6] Propofol for pediatric sedation
    Barnett, P
    [J]. PEDIATRIC EMERGENCY CARE, 2005, 21 (02) : 111 - 114
  • [7] Incidence of adverse events in paediatric procedural sedation in the emergency department: a systematic review and meta-analysis
    Bellolio, M. Fernanda
    Puls, Henrique A.
    Anderson, Jana L.
    Gilani, Waqas I.
    Murad, M. Hassan
    Barrionuevo, Patricia
    Erwin, Patricia J.
    Wang, Zhen
    Hess, Erik P.
    [J]. BMJ OPEN, 2016, 6 (06):
  • [8] Comparison of Propofol Versus Propofol-Ketamine Combination in Pediatric Oncologic Procedures Performed by Non-Anesthesiologists
    Chiaretti, Antonio
    Ruggiero, Antonio
    Barbi, Egidio
    Pierri, Filomena
    Maurizi, Palma
    Fantacci, Claudia
    Bersani, Giulia
    Riccardi, Riccardo
    [J]. PEDIATRIC BLOOD & CANCER, 2011, 57 (07) : 1163 - 1167
  • [9] Propofol: A Review of its Role in Pediatric Anesthesia and Sedation
    Chidambaran, Vidya
    Costandi, Andrew
    D'Mello, Ajay
    [J]. CNS DRUGS, 2015, 29 (07) : 543 - 563
  • [10] Adverse sedation events in pediatrics:: Analysis of medications used for sedation
    Coté, CJ
    Karl, HW
    Notterman, DA
    Weinberg, JA
    McCloskey, C
    [J]. PEDIATRICS, 2000, 106 (04) : 633 - 644